Glioblastoma is a type of brain cancer that affects a considerable percentage of the global population. Thus, it's important to be familiar with its symptoms.

This study proposes to enhance the interpretability of saliency-based deep learning model for survival classification of patients with gliomas, by extracting domain knowledge-based information ...

The FDA has approved an application to initiate a pilot study with Alpha DaRT for patients with recurrent glioblastoma, a ...

DelveInsight’s, “Glioma Pipeline Insight, 2025” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the Glioma pipeline drug ...

More than £1 million has been awarded to seven projects researching brain tumour treatments in Wales. The funding comes from ...

Glioblastoma (GBM), one of the most aggressive ... has an extremely low survival rate, with most patients living only about 12 months after diagnosis. For this reason, scientists have been ...